TFAM and Parkinson disease: A TFAM-mediated “ProtoFection” was employed to deliver mtDNA into the mitochondria of cells representing a model of Parkinson’s disease and resulted in the restoration of mtDNA levels accompanied by the activation of mitochondrial biogenesis [315].